Theratechnologies Receives Final Court Approval for Acquisition by Future Pak

Theratechnologies has received final court approval for its plan of arrangement to be acquired by Future Pak. The acquisition is expected to be completed on or about September 25, 2025, subject to the satisfaction of remaining closing conditions. The company's shareholders approved the arrangement at a special meeting held on September 12, 2025.

Montreal, Sept. 12, 2025 — Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) has announced that its shareholders have approved the company's plan of arrangement to be acquired by Future Pak, LLC. The acquisition, which was approved by 97.44% of the votes cast, is subject to customary closing conditions, including final court approval. The acquisition is expected to be completed on or about September 25, 2025 Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak^[1].

Theratechnologies, a specialty biopharmaceutical company focused on innovative therapies, has received strong support from its shareholders for the proposed acquisition. The arrangement resolution was approved by an overwhelming majority, demonstrating confidence in the proposed transaction. The company's senior vice president and chief financial officer, Philippe Dubuc, stated, "We are pleased with the support from our shareholders and look forward to completing this transaction, which will enhance our ability to deliver patient-centric solutions."

Future Pak, a privately held contract manufacturer, packager, and distributor of pharmaceutical and nutraceutical products, will acquire Theratechnologies. Future Pak operates across retail, specialty, and institutional markets, leveraging its robust infrastructure and partner network to deliver quality-first, patient-centric solutions. The acquisition will allow Future Pak to expand its product offerings and strengthen its position in the biopharmaceutical market.

The proposed arrangement remains subject to certain customary closing conditions, including the issuance of a final order by the Superior Court of Québec following the hearing expected to take place on September 16, 2025. The company has stated that the expected date for the receipt of the final order is September 25, 2025, subject to the satisfaction of remaining closing conditions Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak^[1].

For further information, please contact:
- Theratechnologies Inc.
- Investor inquiries: Philippe Dubuc, Senior Vice President and Chief Financial Officer, pdubuc@theratech.com, 438-315-6608
- Media inquiries: Julie Schneiderman, Senior Director, Communications & Corporate Affairs, communications@theratech.com, 514-336-7800
- Future Pak: media@futurepak.com